Analysis of the role of kynurenine metabolism in drosophila viability control at the high sugar diet influence

  • V. V. Navrotskaya
  • Yu. Yu. Sapota

Abstract

Aim. To analyze viability and life span of drosophila at genetic and pharmacological inhibition of tryptophan-
kynurenine metabolism, when cultivating on the standard nutritive medium and at a high sugar diet. Methods. Wild type stock and the stock with vermilion mutation have been used. Viability (number of individuals, mortality at the pupal stage) and median life span of imagoes have been determined. Results. High sugar diet has been found to negatively affect the viability of drosophila, leading to increased mortality at the pupal stage and decrease of males’ life span; wild-type stock is less resistant to the influence of such diet as compared with mutant stock. Berberine (an inhibitor of tryptophan dioxygenase) when added to the high sugar nutritive medium reduces the negative effect of a high sugar diet on life span of the wild-type stock: males’ life span reaches control values and in females life span is even more than in the control. Conclusions. Decrease of kynurenines content in the flies organisms (both at the genetic and pharmacological inhibition of tryptophan-kynurenine metabolism) may attenuate negative influence of the high sugar diet.

Keywords: drosophila, viability, life span, kynurenine pathway of tryptophan metabolism, high sugar diet.

References

Oxenkrug G. Insulin resistance and dysregulation of tryptophan–kynurenine and kynurenine–nicotinamide adenine dinucleotide metabolic pathways. Mol Neurobiol. 2013. Vol. 48. P. 294–301. doi: 10.1007/s12035-013-8497-4.

Oxenkrug G.F. Increased plasma levels of xanthurenic and kynurenic acids in type 2 diabetes. Mol. Neurobiol. 2015. Vol. 52 (2). P. 805–810. doi: 10.1007/s12035-015-9232-0.

Meiramov G.G., Andreeva A.P., Konert K.D. Investigation of diabetogenic action of xanthurenic acid. Biull Eksp Biol Med. 1997. Vol. 123 (6). P. 669–672. [in Russian]

Oxenkrug G.F., Turski W.A., Zgrajka W., Weinstock J.V., Summergrad P. Tryptophan-kynurenine metabolism and insulin resistance in hepatitis C patients. Hepat. Res. Treat. 2013. ID 149247. doi: 10.1155/2013/149247.

Liu J.J., Movassat J., Portha B. Emerging role for kynurenines in metabolic pathologies. Curr Opin Clin Nutr Metab Care. 2019. Vol. 22 (1). P. 82–90. doi: 10.1097/MCO.0000000000000529.

Musselman L.P., Fink J.L., Narzinski K., Ramachandran P.V., Hathiramani S.S., Cagan R.L., Baranski T.J. A high-sugar diet produces obesity and insulin resistance in wild-type Drosophila. Dis. Model. Mech. 2011. Vol. 4. P. 842–849. doi: 10.1242/dmm.007948.

Navrotskaya V., Oxenkrug G., Vorobyova L., Summergrad P. Attenuation of high sucrose diet–induced insulin resistance in ABC transporter deficient white mutant of Drosophila melanogaster. Integr. Obesity Diabetes. 2016. Vol. 2 (2). P. 187–190. doi: https://doi.org/10.15761/IOD.1000120

Navrotskaya V., Oxenkrug G., Vorobyova L., Summergrad P. Attenuation of high sucrose diet–induced insulin resistance in tryptophan 2,3-dioxygenase deficient Drosophila melanogaster vermilion mutants. Integr. Obesity Diabetes. 2015. Vol. 1 (4). P. 93–95. doi: 10.15761/iod.1000120.

Das S., Das M.K., Mazumder P.M. Cytotoxic activity of methanolic extract of Berberis aristata DC on colon cancer. Global Journal of Pharmacology. 2009. Vol. 3 (3). P. 137–140.

Yu C.J., Zheng M.F., Kuang C.X., Huang W.D., Yang Q. Oren-gedoku-to and its constituents with therapeutic potential in Alzheimer's disease inhibit indoleamine 2, 3-dioxygenase activity in vitro. J. Alzheimers Dis. 2010. Vol. 22 (1). P. 257–266. doi: 10.3233/JAD-2010-100684.

Oxenkrug G. F. The extended life span of Drosophila melanogaster eye-color (white and vermilion) mutants with impaired formation of kynurenine. J. Neural. Transm. 2010. Vol. 117. P. 23–26. doi: 10.1007/s00702-009-0341-7

Ocampo J.R., Huitrón R.L., González-Esquivel D., Ugalde-Muñiz P., Jiménez-Anguiano A., Pineda B., Pedraza-Chaverri J., Ríos C., Pérez de la Cruz V. Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases. Oxidative Medicine and Cellular Longevity. 2014. Vol. 2014. doi:10.1155/2014/646909.

Navrotskaya V. Oxenkrug G., Vorobyova L.I., Summergrad P. Berberine attenuated aging-accelerating effect of high temperature in drosophila model. Amer. J. Plant Sci. 2014. No. 5. P. 275–278. doi: 10.4236/ajps.2014.53037.

Jun Yin, Jianping Ye, Weiping Jia Effects and mechanisms of berberine in diabetes treatment. Acta Pharmaceutica Sinica B. 2012. Vol. 2 (4). P. 327–334. doi: 10.1016/j.apsb.2012.06.003.

Ji H.F., Shen L. Berberine, a potential multipotent natural product to combat Alzheimer’s disease. Molecules. 2011. Vol. 16. P. 6732–6740. doi: 10.3390/molecules16086732.